Published in Exp Cell Res on April 10, 2000
Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci (2007) 1.61
Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology. Dev Biol (2009) 1.24
Signaling networks that control the lineage commitment and differentiation of bone cells. Crit Rev Eukaryot Gene Expr (2009) 1.11
Increased bone formation and decreased osteocalcin expression induced by reduced Twist dosage in Saethre-Chotzen syndrome. J Clin Invest (2001) 0.98
Nuclear factor Y is required for basal activation and chromatin accessibility of fibroblast growth factor receptor 2 promoter in osteoblast-like cells. J Biol Chem (2008) 0.95
Apert p.Ser252Trp mutation in FGFR2 alters osteogenic potential and gene expression of cranial periosteal cells. Mol Med (2007) 0.95
Increased osteoblast apoptosis in apert craniosynostosis: role of protein kinase C and interleukin-1. Am J Pathol (2001) 0.88
Cadherin-mediated cell-cell adhesion and signaling in the skeleton. Calcif Tissue Int (2013) 0.82
Understanding craniosynostosis as a growth disorder. Wiley Interdiscip Rev Dev Biol (2016) 0.79
Synchrotron ultraviolet microspectroscopy on rat cortical bone: involvement of tyrosine and tryptophan in the osteocyte and its environment. PLoS One (2012) 0.78
Molecular analysis of coronal perisutural tissues in a craniosynostotic rabbit model using polymerase chain reaction suppression subtractive hybridization. Plast Reconstr Surg (2011) 0.78
FGF9 on the move. Nat Genet (2009) 0.75
The molecular and cellular basis of Apert syndrome. Intractable Rare Dis Res (2013) 0.75
Signaling mechanisms implicated in cranial sutures pathophysiology: Craniosynostosis. BBA Clin (2016) 0.75
The human sialyltransferase family. Biochimie (2001) 2.39
Spontaneous dissection of the celiac artery. Ann Vasc Surg (2001) 2.22
[Damage control laparotomy for haemorragic abdominal trauma. A retrospective multicentric study about 109 cases]. Ann Chir (2003) 1.97
Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia. Am J Pathol (1997) 1.82
Osteoclasts express high levels of pp60c-src in association with intracellular membranes. J Cell Biol (1992) 1.67
An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res (1993) 1.60
Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. J Cell Physiol (1994) 1.59
Incorporation and distribution of strontium in bone. Bone (2001) 1.40
The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone (1996) 1.38
Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J Biol Chem (2001) 1.38
1994, the year of sialyltransferases. Glycobiology (1995) 1.37
Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med (1980) 1.37
ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity. Glycobiology (2005) 1.36
Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res (1998) 1.32
The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific. J Bone Miner Res (1998) 1.31
Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. J Clin Invest (1998) 1.30
Relation between hypomineralized periosteocytic lesions and bone mineralization in vitamin D-resistant rickets. Calcif Tissue Int (1983) 1.30
Reciprocal control of osteoblast/chondroblast and osteoblast/adipocyte differentiation of multipotential clonal human marrow stromal F/STRO-1(+) cells. J Cell Biochem (2001) 1.24
Evidence for defective osteoblastic function. A role for alcohol and tobacco consumption in osteoporosis in middle-aged men. Clin Orthop Relat Res (1983) 1.17
X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization. J Clin Endocrinol Metab (1981) 1.15
Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells. Metabolism (2004) 1.11
RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation. Cell Death Differ (2006) 1.10
Involvement of glycosylation in the intracellular trafficking of glycoproteins in polarized epithelial cells. Biochimie (2003) 1.09
Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis). J Bone Miner Res (1996) 1.08
GalNAc-alpha-O-benzyl inhibits NeuAcalpha2-3 glycosylation and blocks the intracellular transport of apical glycoproteins and mucus in differentiated HT-29 cells. J Cell Biol (1998) 1.06
Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts. Exp Cell Res (2005) 1.03
Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis. J Bone Miner Res (2001) 1.01
Culture and behavior of osteoblastic cells isolated from normal trabecular bone surfaces. In Vitro Cell Dev Biol (1989) 1.01
S12911-2 reduces bone loss induced by short-term immobilization in rats. Bone (2003) 1.00
Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation. J Cell Biochem (1998) 1.00
Osteopontin is associated with bioprosthetic heart valve calcification in humans. C R Acad Sci III (1997) 1.00
Fibroblast growth factor-2 (FGF-2) increases N-cadherin expression through protein kinase C and Src-kinase pathways in human calvaria osteoblasts. J Cell Biochem (2001) 1.00
Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice. Metabolism (2002) 0.99
Increased bone formation and decreased osteocalcin expression induced by reduced Twist dosage in Saethre-Chotzen syndrome. J Clin Invest (2001) 0.98
Behavior of human osteoblastic cells on stoichiometric hydroxyapatite and type A carbonate apatite: role of surface energy. J Biomed Mater Res (2000) 0.98
Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway. Exp Cell Res (2004) 0.97
Glycol methacrylate as an embedding medium for bone. Stain Technol (1987) 0.96
Identification of two novel conserved amino acid residues in eukaryotic sialyltransferases: implications for their mechanism of action. Glycobiology (1997) 0.96
Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect. Bone (1996) 0.95
N- and E-cadherin mediate early human calvaria osteoblast differentiation promoted by bone morphogenetic protein-2. J Cell Physiol (2000) 0.95
Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation. J Clin Invest (1991) 0.94
E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis. Cell Death Dis (2013) 0.94
The c-Ha-ras oncogene induces increased expression of beta-galactoside alpha-2, 6-sialyltransferase in rat fibroblast (FR3T3) cells. Glycobiology (1992) 0.94
Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA. Glycoconj J (2003) 0.93
Age-related changes in bone formation, osteoblastic cell proliferation, and differentiation during postnatal osteogenesis in human calvaria. J Cell Biochem (1997) 0.93
Thrombospondin is synthesized and secreted by human osteoblasts and osteosarcoma cells. A model to study the different effects of thrombospondin in cell adhesion. Eur J Biochem (1989) 0.93
Vitamin D dependency: replacement therapy with calcitriol? J Pediatr (1981) 0.93
Osteoblastic cells derived from isolated lesions of fibrous dysplasia contain activating somatic mutations of the Gs alpha gene. Hum Mol Genet (1995) 0.92
Plasticity and regulation of human bone marrow stromal osteoprogenitor cells: potential implication in the treatment of age-related bone loss. Histol Histopathol (2004) 0.92
Sequential expression of bone matrix proteins during rat calvaria osteoblast differentiation and bone nodule formation in vitro. J Histochem Cytochem (1997) 0.91
Isolation and characterization of human clonogenic osteoblast progenitors immunoselected from fetal bone marrow stroma using STRO-1 monoclonal antibody. J Bone Miner Res (1999) 0.91
Multiplex RT-PCR method for the analysis of the expression of human sialyltransferases: application to breast cancer cells. Glycoconj J (1998) 0.91
O-glycosylation potential of lepidopteran insect cell lines. Biochim Biophys Acta (1999) 0.91
Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse. Calcif Tissue Int (1982) 0.91
Skeletal unloading induces osteoblast apoptosis and targets alpha5beta1-PI3K-Bcl-2 signaling in rat bone. Exp Cell Res (2006) 0.90
Differential effect of GalNAcalpha-O-bn on intracellular trafficking in enterocytic HT-29 and Caco-2 cells: correlation with the glycosyltransferase expression pattern. J Cell Sci (2001) 0.90
Characterization of mucins and proteoglycans synthesized by a mucin-secreting HT-29 cell subpopulation. J Cell Sci (1995) 0.90
Activation of phospholipase C-beta1 via Galphaq/11 during calcium mobilization by calcitonin gene-related peptide. J Biol Chem (1998) 0.90
Temporal variation of c-Fos proto-oncogene expression during osteoblast differentiation and osteogenesis in developing rat bone. J Cell Biochem (1995) 0.90
Effects of iron overload on bone remodeling in pigs. Am J Pathol (1984) 0.89
c-fos protooncogene is involved in the mitogenic effect of transforming growth factor-beta in osteoblastic cells. Mol Endocrinol (1995) 0.89
Characterization of endosteal osteoblastic cells isolated from mouse caudal vertebrae. Bone (1988) 0.89
Insulin-like growth factor-I increases trabecular bone formation and osteoblastic cell proliferation in unloaded rats. Endocrinology (1994) 0.89
Short-term effects of fluoride and strontium on bone formation and resorption in the mouse. Metabolism (1986) 0.88
Increased osteoblast apoptosis in apert craniosynostosis: role of protein kinase C and interleukin-1. Am J Pathol (2001) 0.88
Short-term effects of organic silicon on trabecular bone in mature ovariectomized rats. Calcif Tissue Int (1993) 0.87